Igg-based b7-h3xcd3 bispeci c antibody for treatment of pancreatic, hepatic and gastric cancer

HIGHLIGHTS

  • who: -H et al. from the The Chinese University of Hong Kong, China have published the Article: IgG-based B7-H3xCD3 bispeci c antibody for treatment of pancreatic, hepatic and gastric cancer, in the Journal: (JOURNAL)
  • what: The authors report on the preclinical characterization of a bsAb targeting B7-H3 and CD3 for treatment of gastric, hepatic and pancreatic cancer.
  • how: Measurements were performed using a FACS Canto II or FACS Fortessa (BD Biosciences San Diego CA) and data was analyzed using the software FlowJo (FlowJo LCC Ashland OR).

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?